ArticleInvestigative ophthalmology & visual science2026
NEDD8 Promotes the Progression and Inflammation of Keratoconus by Increasing the Expression of YAP1.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- PSMA6 drives non-small cell lung cancer progression by stabilizing NEDD8 and activating NF-κB signaling.Translational lung cancer research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Keratoconus (KC) is an adolescent-onset vision-impairing corneal disorder with incompletely elucidated pathogenesis. This study aims to elucidate the regulatory role of NEDD8 in the Hippo-YAP signaling pathway and its influence on the corneal pathology, thereby providing a theoretical basis for mechanistic studies and targeted therapy of KC. Methods: Single-cell RNA sequencing (scRNA-seq) analysis of central corneas was performed to identify differentially expressed molecules and signaling pathways in KC. Then the expression changes and correlations of key regulatory molecules were validated at both the transcriptional and protein levels. We subjected HTK cells to mechanical stretch and used gain- or loss-of-function assays to demonstrate the regulatory role of key signaling pathways. In addition, ligand-receptor interaction analysis was performed to decipher aberrant immune-stromal cell crosstalk in KC. Results: NEDD8 was significantly upregulated in KC corneal stromal cells, with decreased MST1/LATS1 expression and increased YAP1 nuclear translocation. In vitro experiments indicated that mechanical stretch may inhibit the Hippo pathway by upregulating NEDD8, thereby reducing YAP1 phosphorylation and enhancing its transcriptional activity. We detected signs of elevated inflammation and dysregulated stromal-immune ligand-receptor pairs in KC samples. Overexpression of NEDD8 and YAP1 significantly increased inflammatory cytokine levels in HTK cells, whereas NEDD8 inhibitor treatment suppressed the mechanical stretch-triggered inflammatory responses. Conclusions: Collectively, our study revealed that NEDD8 may promote KC progression by mediating mechanical signal transduction through regulation of the Hippo-YAP pathway. These findings highlight NEDD8 as a promising therapeutic target for KC and provide novel mechanistic insights into its molecular pathogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.